Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.jaip.2018.05.029 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Background: Functional immune reconstitution (IR) is a key factor in determining the success of hematopoietic stem cell transplantation (HSCT). IR depends on a number of factors and is typically delayed by ex vivo T cell depletion of the graft. αβ T cell depletion (αβ TCD) platform was reported to be associated with improved IR.
View Article and Find Full Text PDFRapid Donor-Specific Antibodies Clearance With Short-Course Blinatumomab Prior to Haploidentical HSCT: A Case of Successful Engraftment.
Pediatr Blood Cancer
August 2025
Division of Hematology/Oncology, Children's Hospital of Zhejiang University School of Medicine, Hangzhou, China.
Immunotherapy with ex vivo-expanded donor-derived NK cells after haploidentical HSCT in pediatric patients with AML: a phase I pilot study.
Curr Res Transl Med
August 2025
Hematologic Malignancies Research Center, Research Institute for Oncology, Hematology and Cell Therapy, Tehran University of Medical Sciences, Tehran, Iran.
Background: Post-transplant relapse remains a considerable challenge for achieving successful outcomes in pediatric patients with acute myeloid leukemia (AML) receiving haploidentical hematopoietic stem cell transplantation (HSCT). Adoptive immune cell therapy strategies utilizing highly purified donor-derived natural killer (NK) cells have been extensively explored in various transplantation settings, demonstrating promise in preventing disease recurrence, especially in pediatric AML patients.
Methods: Five pediatric and adolescent patients with high-risk AML were included in this pilot study and received haploidentical HSCT.
Autologous Cord Blood Transplantation for Idiopathic Severe Aplastic Anemia.
J Pediatr Hematol Oncol
August 2025
Children's Haematology & Cancer Centre, Mount Elizabeth Hospital, Singapore.
Cord blood units are seldom used for autologous transplantation and selection criteria have not been defined. A 6-year-old male with severe aplastic anemia received an autologous cord blood transplantation containing total nucleated cells (TNC) 2.0×107/kg and CD34+0.
View Article and Find Full Text PDF